DRAPER, Utah, Jan. 2, 2014 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to provide this brief report to shareholders regarding the Company's recently filed Form 10-Q for the quarterly period ended October 31, 2013.
"Knowing that the upfront costs of going public are high and that the added regulatory and audit responsibilities involved would distract my office and sales teams, I'm very satisfied with our recent financial performance," stated Dr. Tracy K. Gibbs, Nutranomics' CEO. "In fact, I am pleased to say that we finished our first quarter with a smaller loss than expected, and now that our public company funding is in place, our new sales teams are focused on performance and positioned to fully execute our market expansion strategies for 2014 and beyond."
Mike Brousseau, General Manager of Nutranomics concluded, "With the addition of five new sales reps and two new back office support staff during the month of December, our entire team has been dedicated to training and preparation for executing our very ambitious expansion strategy. We are extremely excited about our growth prospects and new additions to our team, and look forward to positive results in 2014."
Nutranomics is a publicly traded company engaged in research and development of nutritional food products. In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public. Nutranomics has also produced formulas for hundreds of other companies. Nutranomics' mission is to increase human health and longevity through education and self-awareness. The Company has sales representatives throughout North America and Asia.
For further information regarding Nutranomics, Inc., please contact our investor relations representatives at email@example.com or call toll-free (888) 616-3999.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include the Company's expectation of positive future results from sales efforts and expansion strategies. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
SOURCE Nutranomics, Inc.